Back to search

Article

<em>BRCA1/2</em> Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data Study

2024-04-09

Abstract excerpt

Analyzing BRCA1/2 tumor pathogenic variants (TPVs) in epithelial tubal/ovarian cancers (EOC) has become an essential part of the diagnostic workflow in many centers to guide treatment options and genetic cascade testing. However, there is no standardization of testing procedures, including techniques, gene assays, or sequencers used, and data on the execution of tumor tests remains scarce. Therefore, we evaluated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f315854a-d4c2-5756-98f4-15fc7c2a116a
DOI
10.20944/preprints202404.0636.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<em>BRCA1/2</em> Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data StudyDOI 10.20944/preprints202404.0636.v1
Evaluation of BRCA1/2 testing rates in epithelial ovarian cancer patients: lessons learned from real-world clinical data.Semantic proximity
BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients.Semantic proximity
Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).Semantic proximity
Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.Semantic proximity
BRCA1/2 Mutation Testing Among Adult Women With HER2-Negative Advanced Breast Cancer: Results From a Multi-Country, Real-World StudySemantic proximity
Nationwide implementation and evaluation of the Tumor-First workflow for genetic testing in ovarian carcinoma.Semantic proximity
Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic PredispositionSemantic proximity
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease PreventionSemantic proximity
Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian CancerSemantic proximity
Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study.Semantic proximity
Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.Semantic proximity
Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.Semantic proximity
Select a neighboring publication to make it the new centre.